User profiles for "author:J Buckels"
John BuckelsUniversity of Birmingham Verified email at blueyonder.co.uk Cited by 17941 |
Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis
Background: Needle biopsy of a suspicious liver lesion could guide management in the
setting of equivocal imaging and serology, although it is not recommended generally …
setting of equivocal imaging and serology, although it is not recommended generally …
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial
Context Adjuvant fluorouracil has been shown to be of benefit for patients with resected
pancreatic cancer. Gemcitabine is known to be the most effective agent in advanced disease …
pancreatic cancer. Gemcitabine is known to be the most effective agent in advanced disease …
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized …
…, L Fernandez-Cruz, F Lacaine, J Buckels… - Annals of …, 2001 - journals.lww.com
Objective To assess the influence of resection margins on survival for patients with resected
pancreatic cancer treated within the context of the adjuvant European Study Group for …
pancreatic cancer treated within the context of the adjuvant European Study Group for …
PORTAL VEIN THROMBOSIS IN ADULTS UNDERGOING LIVER TRANSPLANTATION: Risk Factors, Screening, Management, and Outcome: 1
Background. Portal vein thrombosis (PVT) has been seen as an obstacle to liver
transplantation (LTx). Recent data suggest that favorable results may be achieved in this …
transplantation (LTx). Recent data suggest that favorable results may be achieved in this …
[HTML][HTML] A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients …
SR Bramhall, J Schulz, J Nemunaitis, PD Brown… - British journal of …, 2002 - nature.com
Pancreatic cancer is the fifth most common cause of cancer death in the western world and
the prognosis for unresectable disease remains poor. Recent advances in conventional …
the prognosis for unresectable disease remains poor. Recent advances in conventional …
Bile duct injury following laparoscopic cholecystectomy: referral pattern and management
DF Mirza, KL Narsimhan, BHF Neto… - British journal of …, 1997 - Wiley Online Library
Background Laparoscopic cholecystectomy is associated with a higher incidence of bile
duct injury than open cholecystectomy. This study reviews the management of bile duct …
duct injury than open cholecystectomy. This study reviews the management of bile duct …
Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial
SR Bramhall, A Rosemurgy, PD Brown… - Journal of Clinical …, 2001 - ascopubs.org
PURPOSE: The prognosis for unresectable pancreatic cancer remains dismal (1-year
survival rate,< 10%; 5-year survival rate,< 5%). Recent advances in conventional …
survival rate,< 10%; 5-year survival rate,< 5%). Recent advances in conventional …
3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome
Background Mortality after liver transplantation depends on heterogeneous recipient and
donor factors. Our aim was to assess risk of death and to develop models to help predict …
donor factors. Our aim was to assess risk of death and to develop models to help predict …
Hepatic artery thrombosis following orthotopic liver transplantation: a 10‐year experience from a single centre in the United Kingdom
MA Silva, PS Jambulingam, BK Gunson… - Liver …, 2006 - Wiley Online Library
Hepatic artery thrombosis (HAT) occurs in 3–9% of all liver transplants and acute graft loss is
a possible sequelae. We present our experience in the management of HAT over a 10‐year …
a possible sequelae. We present our experience in the management of HAT over a 10‐year …
A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin
DH Palmer, DD Stocken, H Hewitt, CE Markham… - Annals of surgical …, 2007 - Springer
Background Survival after surgery for pancreas cancer remains low. This improves with
adjuvant chemotherapy, but up to 30% patients do not receive the prescribed treatment …
adjuvant chemotherapy, but up to 30% patients do not receive the prescribed treatment …